Updated company overview and presentation, current as of March 2012.

1. MEDICAL PRACTICE MANAGEMENT SERVICES
OTC Pink: MHCC
Web Business Outline Presentation March 17, 2012

2. Common Stock Overview
Symbol: MHCC: Alternative-reporting OTC Pink
Common Shares Outstanding a/o 11/30/11: 16,919,122
Market Capitalization @$1.25: $21,150,000
RECENT PRESS RELEASES:
Mar. 7, 2012 ‐ Millennium HealthCare appoints Ed Joyce to Company Advisory Board
Dec. 23, 2011 – Millennium HealthCare appoints Elias Zias, MD to Company Advisory Board
Dec. 21, 2011 – Millennium HealthCare appoints Marc Sherman, MD to Company Advisory Board
Nov. 16, 2011 – Millennium HealthCare signs Letter of Intent to acquire Practice Management
Company Specializing in Cardiovascular Services
Nov. 11, 2011 ‐ Millennium HealthCare developing and managing first Vascular Surgical Facility
Nov. 10, 2011 ‐ Millennium HealthCare completes acquisition of Premier Technology Resources,
LLC
2

3. Company Overview
Millennium Vascular Management Group, our primary operating subsidiary, offers physician
practice development and management services for their facilities and physician practices
with a focus on vascular disorders. Through our extensive experience and comprehensive
suite of management services and support, we create environments in which essential cardio
and vascular access care is provided effectively and efficiently, with optimal outcomes for
both physician and patient.
Our Practice Management Group develops, supports and manages physician practices
specializing in the diagnosis and treatment of Peripheral Arterial Disease (PAD) of the lower
extremities. We also provide physician practices and facilities with comprehensive business
management, procedure/operating room build‐out and management, physician recruitment,
IT support and services. We also provide marketing and business consulting services,
including market analysis and assessment, equipment procurement, credentialing, practice
management, coding and billing, call/message management and emergency dispatch and
general overall business management.
3

4. Facility Geographical Targets Procedural Focus
2012
‐Staten Island, NY ‐ Lower Extremity Arterial Diagnosis
‐Queens, NY ‐ Catheter Placement
‐Central NJ ‐ Catheter Removal
‐Florida ‐ Venous PTA / Stent
‐Philadelphia, PA ‐ Arterial PTA
‐Atlanta. GA ‐ Arterial Stent Placement
‐Southern NJ ‐ Atherectomy
‐Westchester, NY
‐Bryn Mawr, PA
4

5. Business Development Strategy
• Experienced Management Team with significant outpatient
cardiology & vascular expertise.
• Identification of initial national footprint .
• Current Marketplace ripe for expansion
• High Margin/Significant Cash‐Flow Opportunity
• Current Insurance reimbursement favorable versus Hospital alternative
• Beneficial for Patient & Physician
5

6. Millennium Vascular Management Group
of Staten Island
Opened February 9, 2012
6

7. Millennium Vascular Management Group
of West Palm Beach
Scheduled Opening June 1, 2012
7

8. Industry Facts & Trends
Disease and Stroke Statistics‐2011 Update:
Cardio Vascular Diseases and stroke accounted for 15% of the total health
expenditures in the United States in 2007.
Peripheral arterial disease (PAD) affects 8 million Americans.
PAD affects 12% to 20% of Americans 65 years of age.
The total direct and indirect cost of CVD and stroke in the United States for 2007
is estimated to be $286 billion.
88

9. Cardiovascular disease and
other major causes of death
for all males & females
(USA‐2007)
Males
SOURCE:
http://circ.ahajornals.org/
Females
9

10. Vascular / CardioCare
Independent Practices that blend together
Vascular Surgical Facility
‐Surgical Procedures
Procedural Focus:
‐Lower Extremity Arterial Diagnosis CARDIO
‐Catheter Placement CARE
‐Catheter Removal CARDIO Practice
‐Venous PTA / Stent CARDIO
CARE
‐Arterial PTA CARE
Practice
Practice
‐Arterial Stent Placement
‐Atherectomy
CardioCare Practice
‐Testing CARDIO CARDIO
‐Initial patient evaluation & CARE VASCULAR Facility CARE
consultation Practice Practice
‐EKG
‐Echocardiogram
‐Stress Echocardiogram
‐Abdominal Aorta
‐Renal Doppler
‐Arterial Duplex
‐Venous Duplex
‐PVR CARDIO CARDIO
‐Holter Monitoring CARE CARE
‐ABI Practice Practice
CARDIO
‐Exercise PVR CARE
‐Pulmonary Stress Test Practice
‐Nuclear Stress testing
‐Cardiac PET
10

11. Millennium CardioCare
Cardiology Service
Offered to existing medical practices that do not provide Cardiology in‐house and
want to retain patient flow within their practice. A “Cardio Care” Cardiologist will
come to see patients in the existing practice offices on a scheduled basis and will
provide full Cardiology evaluation & testing.
Geographical Targets for 2012
Millennium Cardiology Practice Management ‘s ‐New York
physician patient mix represents the first introduction to a ‐Florida
cardio patient that may be requiring more advanced care. Our ‐New Jersey
managed Vascular Facilities will be geographically located ‐Georgia
near many CardioCare practice locations to offer an ‐Alabama
alternative option to deliver patient comfort and superior care .
‐PA
Market Segment Strategic Advantages:
‐ Insurance Carriers pay for pre‐cursor testing & minimally invasive medical
procedures to avoid long hospital stays and open procedures.
‐ target physicians in highly populated urban areas.
‐ Cardio model offers many medical groups the flexibility to keep patients in
house with advanced cardio testing & physician access.
‐ Introducing skilled cardiovascular surgeons to non‐invasive cardiology
practices.
11

12. Additional Services Offered:
Billing Services
• Billing and Collections
• Electronic Medical Records
Coding Services
• Secure Remote or On‐Site Coding
Medical Devices
• Vascular Examinations Kits
ProComm Services
•Reliable Live Answering 24/7 Full Service Call Processing
12

13. MANAGEMENT TEAM
• Dominick Sartorio – CEO & Chairman of Millennium HealthCare Inc. served as Director of New
Business for a Wall Street management consulting firm creating and implementing initiatives for
client companies’ worth up to $550 million in annual sales. Mr. Sartorio was placed as acting CEO of
a global technology firm, directing the research and development process, patent approval, product
launch, and the negotiation of a 2‐year, $800 million sales agreement. Prior, Mr. Sartorio co‐
founded a highly successful manufacturing and distribution company maintaining global reach in
numerous industries such as medical, chemical and emerging technology markets. During his
tenure, Mr. Sartorio vastly improved the profitability and cash flow of numerous holding companies
implementing efficiencies, policies and procedures that had a global impact . Among Mr. Sartorio’s
achievements was the development of the world’s largest synthetic vitamin B4 and antioxidant
manufacturing facility. Under his leadership, this facility produced millions of pounds of product per
year while remaining in compliance with standards set forth by the Food and Drug Administration
(FDA), the Environmental Protection Agency (EPA), the Occupational Safety and Health
Administration (OSHA) and the Drug Enforcement Agency (DEA).
• Chris Amandola – President & Director has more than 15 years of Professional Management,
Senior Management and Entrepreneurial experience in the Medical device arena. Chris has held
positions at such high profiled Medical device Companies like C.R. Bard Inc., Boston Scientific
Corp. and Smith & Nephew Inc. Chris has experience and extensive knowledge in fields of
Peripheral Vascular, Coronary, Gastroenterology, Wound Care and Infection Control.
13

14. MANAGEMENT TEAM
• Anthony Urbano ‐ Chief Financial Officer, Secretary & Director has over 18 years of forensic and
financial accounting, finance, administration, operational, sales/marketing budgets and projections,
advisory and managerial experience in entrepreneurial and high‐growth companies.
• Richard DeMaio – Chief Information Officer is currently the President of Heartbeat Medical PC, an
AMSURG‐Cardiology Center and Management Services Organization that provides a full suite of
consulting services to private practices, AMSURG facilities and hospitals.
• Mark Allen – Regional Director of Sales‐ has close to 20 years of Medical device sales, sales
management and medical recruiting. Mark has held positions at some of the premiere medical
device companies in the industry, Stryker, Inamed, Abbot Vascular, to name a few.
14

15. ADVISORY BOARD MEMBERS
• Marc Sherman, MD FACC currently serves as the Medical Director of Heartbeat Medical PC
and is also an active member with Medical Health Associates of Bellerose, DOC Care,
Midtown Internal Medicine, R and L Medical Associates and Total Medical PC
• Elias Zias, MD currently serves as attending physician at St. John’s Medical Center, St.
Joseph’s Medical Center, Community Hospital at Dobbs Ferry, Hudson Valley Hospital Center
and NY School of Medicine NYU Langone Medical Center.
• Edward Joyce – Vice President of Sales and Marketing ‐ has over 17 years experience in
medical sales and medical sales management. Edward has spent time with and has a long
history of success with leading medical device manufacturers such as C.R. Bard Inc., Edwards
Life sciences and St. Jude Medical.
15

16. Safe Harbor Statement Under the Private Securities Litigation Act of 1995
With the exception of historical information, the matters discussed herein are forward‐looking
statements that involve a number of risks and uncertainties. The actual future results of Millennium
Healthcare, Inc.(the “Company”) could differ significantly from those statements. Factors that could
cause actual results to differ materially include risks and uncertainties such as the inability to finance the
company's operations or expansion, inability to hire and retain qualified personnel, changes in the
general economic climate, including rising interest rate and unanticipated events such as terrorist
activities.
In some cases, you can identify forward‐looking statements by terminology such as "may," "will,"
"should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the
negative of such terms, or other comparable terminology. These statements are only predictions.
Although we believe that the expectations reflected in the forward‐looking statements are reasonable,
such statements should not be regarded as a representation by the Company, or any other person, that
such forward‐looking statements will be achieved, particularly if we have provided projected revenues
or forecasts, which are all simply estimates based on the opinions of management. We undertake no
duty to update any of the forward‐looking statements, whether as a result of new information, future
events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such
forward‐looking statements. For further risk factors see the risk factors associated with our Company,
please review our OTC Markets filings.
16